STOCK TITAN

Astrana Health CEO withholds 7.2K shares for tax

Astrana Health’s CEO surrendered shares to cover RSU tax withholding while retaining a substantial direct and trust-related equity position.

(High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Astrana Health, Inc. (ASTH) reported that CEO and President Brandon Sim surrendered 7,163 shares of common stock on September 5, 2026 to pay tax withholding obligations associated with vested restricted stock units, at a reported price of $38.47 per share. This tax-withholding disposition did not involve an open-market sale and no Rule 10b5-1 trading plan is reported. Following the transaction, he holds 1,238,861 shares directly, including unvested restricted stock and restricted stock units scheduled to vest over multiple semi-annual installments, and also has indirect interests in shares held by two irrevocable trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Sim Brandon
Role CEO and President
Type Security Shares Price Value
Tax Withholding Common Stock F3, F4, F5 7,163 $38.47 $276K
holding Common Stock F1 -- -- --
holding Common Stock F2 -- -- --
Holdings After Transaction: Common Stock — 1,238,861 shares (Direct); Common Stock — 258,824 shares (Indirect, By Sim Family Irrevocable Trust 2021); Common Stock — 392,816 shares (Indirect, By Brandon Sim 2020 Irrevocable Trust)
Footnotes (5)
  1. F1. These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. F2. These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  3. F3. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026.
  4. F4. Includes 34,207 shares of unvested restricted stock, which will vest in two equal semi-annual installments, beginning September 30, 2026, subject to continuous employment with the Issuer. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 91,027 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026.
  5. F5. Includes 2,152 shares acquired under the Issuer's Employee Stock Purchase Plan.
Shares surrendered for tax withholding 7,163 shares Common stock surrendered on September 5, 2026 to offset RSU-related tax withholding
Reported price per share $38.47 per share Value used for the 7,163-share tax-withholding disposition on September 5, 2026
Direct holdings after transaction 1,238,861 shares Common stock directly owned by Brandon Sim following the September 5, 2026 transaction
Indirect holdings – Sim Family Irrevocable Trust 2021 258,824 shares Common stock held by the Sim Family Irrevocable Trust 2021; beneficial ownership disclaimed except for pecuniary interest
Indirect holdings – Brandon Sim 2020 Irrevocable Trust 392,816 shares Common stock held by the Brandon Sim 2020 Irrevocable Trust; beneficial ownership disclaimed except for pecuniary interest
Unvested restricted shares 34,207 shares Unvested restricted stock included in direct holdings, vesting in two equal semi-annual installments beginning September 30, 2026
Restricted stock units scheduled to vest 60,347; 91,027; 201,056 units Three RSU grants vesting in semi-annual installments beginning October 2, 2026; March 5, 2027; and October 6, 2026, respectively
ESPP shares included in holdings 2,152 shares Shares acquired under Astrana Health’s Employee Stock Purchase Plan and included in direct ownership
restricted stock units financial
"restricted stock units that vested on September 5, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
unvested restricted stock financial
"Includes 34,207 shares of unvested restricted stock, which will vest"
Employee Stock Purchase Plan financial
"Includes 2,152 shares acquired under the Issuer's Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"
beneficial ownership financial
"the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

What transaction did ASTH CEO Brandon Sim report on September 5, 2026?

He reported a tax-withholding disposition of 7,163 Astrana Health (ASTH) shares of common stock, surrendered to offset tax withholding obligations tied to restricted stock units that vested on September 5, 2026, at a reported price of $38.47 per share.

Was the ASTH CEO’s September 5, 2026 Form 4 transaction an open-market sale?

No. The filing states the 7,163-share transaction was a payment of tax liability by delivering or withholding securities related to vested restricted stock units, not an open-market sale of Astrana Health (ASTH) shares.

How many ASTH shares does CEO Brandon Sim hold directly after this Form 4?

After the September 5, 2026 transaction, Brandon Sim holds 1,238,861 Astrana Health (ASTH) shares directly. This amount includes unvested restricted stock and several tranches of restricted stock units scheduled to vest in future semi-annual installments.

What indirect Astrana Health (ASTH) holdings are reported for Brandon Sim?

The Form 4 lists 258,824 shares held by the Sim Family Irrevocable Trust 2021 and 392,816 shares held by the Brandon Sim 2020 Irrevocable Trust. He disclaims beneficial ownership of these, except to the extent of his pecuniary interest.

Are any of the ASTH CEO’s future equity awards subject to vesting conditions?

Yes. The filing notes 34,207 unvested restricted shares plus several blocks of restricted stock units (60,347; 91,027; 201,056 units) that will vest in semi-annual installments beginning between September 30, 2026 and March 5, 2027, subject to continuous employment.

Did the ASTH CEO acquire any shares through an Employee Stock Purchase Plan?

Yes. The post-transaction holdings disclosure states that his direct holdings include 2,152 shares acquired under Astrana Health’s Employee Stock Purchase Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sim Brandon

(Last)(First)(Middle)
C/O ASTRANA HEALTH, INC.
1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)
ALHAMBRA CALIFORNIA 91801

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CEO and President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/05/2026F7,163(3)D$38.471,238,861(4)(5)D
Common Stock258,824IBy Sim Family Irrevocable Trust 2021(1)
Common Stock392,816IBy Brandon Sim 2020 Irrevocable Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on September 5, 2026.
4. Includes 34,207 shares of unvested restricted stock, which will vest in two equal semi-annual installments, beginning September 30, 2026, subject to continuous employment with the Issuer. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 60,347 restricted stock units, which will vest in four equal semi-annual installments beginning on October 2, 2026; (ii) 91,027 restricted stock units, which will vest in five equal semi-annual installments beginning on March 5, 2027; and (iii) 201,056 restricted stock units, which will vest in eight equal semi-annual installments beginning on October 6, 2026.
5. Includes 2,152 shares acquired under the Issuer's Employee Stock Purchase Plan.
/s/ Kathy Diep, as Attorney-in-Fact09/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading